Plymouth, United Kingdom · Founded 2018 · Privately Held (backing)
Developer of antimicrobial-resistant drugs designed to combat drug-resistant infections. Amprologix is based in Plymouth, United Kingdom and was founded in 2018. Its last reported valuation was $10.9 million in Oct 2025. It has raised $1 million.
Last reported valuation
$10.9M
Oct 2026
Priced at
—
Total raised
$1.0M
Last round
—
Cap table — not yet on record
Amprologix's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Amprologix with a free account
·Watch Amprologix: the Monday email on marks, rounds and moves
